nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—NT5E—brown adipose tissue—adrenal gland cancer	0.0828	0.186	CbGeAlD
Cytarabine—POLB—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.0673	0.131	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0267	0.0521	CbGpPWpGaD
Cytarabine—POLD1—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.0258	0.0503	CbGpPWpGaD
Cytarabine—DCTD—Nucleotide metabolism—RRM1—adrenal gland cancer	0.0256	0.0498	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—RRM1—adrenal gland cancer	0.0185	0.0361	CbGpPWpGaD
Cytarabine—POLB—gonad—adrenal gland cancer	0.0184	0.0414	CbGeAlD
Cytarabine—POLB—pituitary gland—adrenal gland cancer	0.018	0.0403	CbGeAlD
Cytarabine—DCTD—adrenal cortex—adrenal gland cancer	0.0179	0.0402	CbGeAlD
Cytarabine—POLA1—Nucleotide Metabolism—RRM1—adrenal gland cancer	0.0177	0.0346	CbGpPWpGaD
Cytarabine—POLB—adrenal gland—adrenal gland cancer	0.0161	0.036	CbGeAlD
Cytarabine—POLD1—gonad—adrenal gland cancer	0.0151	0.0338	CbGeAlD
Cytarabine—DCTD—gonad—adrenal gland cancer	0.0149	0.0333	CbGeAlD
Cytarabine—DCTD—cardiac atrium—adrenal gland cancer	0.0148	0.0333	CbGeAlD
Cytarabine—NT5E—Nucleotide metabolism—RRM1—adrenal gland cancer	0.0147	0.0286	CbGpPWpGaD
Cytarabine—DCTD—pituitary gland—adrenal gland cancer	0.0145	0.0325	CbGeAlD
Cytarabine—CDA—Nucleotide metabolism—RRM1—adrenal gland cancer	0.0134	0.0262	CbGpPWpGaD
Cytarabine—Clofarabine—RRM1—adrenal gland cancer	0.0134	0.326	CrCbGaD
Cytarabine—POLD1—adrenal gland—adrenal gland cancer	0.0131	0.0294	CbGeAlD
Cytarabine—Fludarabine—RRM1—adrenal gland cancer	0.013	0.316	CrCbGaD
Cytarabine—DCTD—adrenal gland—adrenal gland cancer	0.013	0.0291	CbGeAlD
Cytarabine—Gemcitabine—RRM1—adrenal gland cancer	0.0123	0.298	CrCbGaD
Cytarabine—SLC22A2—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0121	0.0236	CbGpPWpGaD
Cytarabine—CDA—adrenal gland—adrenal gland cancer	0.0118	0.0264	CbGeAlD
Cytarabine—NT5E—gonad—adrenal gland cancer	0.0115	0.0258	CbGeAlD
Cytarabine—NT5E—cardiac atrium—adrenal gland cancer	0.0115	0.0258	CbGeAlD
Cytarabine—POLE—gonad—adrenal gland cancer	0.0113	0.0253	CbGeAlD
Cytarabine—SLC22A1—Abacavir transmembrane transport—ABCB1—adrenal gland cancer	0.0113	0.022	CbGpPWpGaD
Cytarabine—NT5E—pituitary gland—adrenal gland cancer	0.0112	0.0252	CbGeAlD
Cytarabine—POLE—pituitary gland—adrenal gland cancer	0.011	0.0246	CbGeAlD
Cytarabine—CYP3A4—urine—adrenal gland cancer	0.0106	0.0238	CbGeAlD
Cytarabine—NT5E—adrenal gland—adrenal gland cancer	0.01	0.0225	CbGeAlD
Cytarabine—POLE—adrenal gland—adrenal gland cancer	0.00982	0.022	CbGeAlD
Cytarabine—POLA1—pituitary gland—adrenal gland cancer	0.00947	0.0212	CbGeAlD
Cytarabine—ABCC10—ABC-family proteins mediated transport—ABCB1—adrenal gland cancer	0.00942	0.0184	CbGpPWpGaD
Cytarabine—POLA1—adrenal gland—adrenal gland cancer	0.00846	0.019	CbGeAlD
Cytarabine—DCK—Nucleotide metabolism—RRM1—adrenal gland cancer	0.00783	0.0153	CbGpPWpGaD
Cytarabine—SLC29A1—adrenal cortex—adrenal gland cancer	0.00757	0.017	CbGeAlD
Cytarabine—POLA1—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—adrenal gland cancer	0.00738	0.0144	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00737	0.0144	CbGpPWpGaD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—ABCB1—adrenal gland cancer	0.00726	0.0142	CbGpPWpGaD
Cytarabine—DCK—adrenal cortex—adrenal gland cancer	0.00723	0.0162	CbGeAlD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00718	0.014	CbGpPWpGaD
Cytarabine—SLC22A2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00694	0.0135	CbGpPWpGaD
Cytarabine—ABCC10—adrenal cortex—adrenal gland cancer	0.00689	0.0154	CbGeAlD
Cytarabine—POLD1—Extension of Telomeres—TERT—adrenal gland cancer	0.0068	0.0133	CbGpPWpGaD
Cytarabine—POLE—Extension of Telomeres—TERT—adrenal gland cancer	0.00657	0.0128	CbGpPWpGaD
Cytarabine—SLC22A1—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00647	0.0126	CbGpPWpGaD
Cytarabine—SLC29A1—gonad—adrenal gland cancer	0.00627	0.0141	CbGeAlD
Cytarabine—SLC29A1—cardiac atrium—adrenal gland cancer	0.00626	0.014	CbGeAlD
Cytarabine—NT5E—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.00621	0.0121	CbGpPWpGaD
Cytarabine—SLC29A1—pituitary gland—adrenal gland cancer	0.00611	0.0137	CbGeAlD
Cytarabine—POLA1—E2F transcription factor network—RRM1—adrenal gland cancer	0.00604	0.0118	CbGpPWpGaD
Cytarabine—DCK—gonad—adrenal gland cancer	0.00599	0.0134	CbGeAlD
Cytarabine—DCK—cardiac atrium—adrenal gland cancer	0.00598	0.0134	CbGeAlD
Cytarabine—DCK—pituitary gland—adrenal gland cancer	0.00584	0.0131	CbGeAlD
Cytarabine—ABCC10—gonad—adrenal gland cancer	0.0057	0.0128	CbGeAlD
Cytarabine—ABCC10—cardiac atrium—adrenal gland cancer	0.0057	0.0128	CbGeAlD
Cytarabine—ABCC10—pituitary gland—adrenal gland cancer	0.00556	0.0125	CbGeAlD
Cytarabine—SLC29A1—adrenal gland—adrenal gland cancer	0.00546	0.0122	CbGeAlD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00525	0.0102	CbGpPWpGaD
Cytarabine—DCK—adrenal gland—adrenal gland cancer	0.00522	0.0117	CbGeAlD
Cytarabine—ABCC10—adrenal gland—adrenal gland cancer	0.00497	0.0111	CbGeAlD
Cytarabine—POLA1—Extension of Telomeres—TERT—adrenal gland cancer	0.00468	0.00913	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.00455	0.00888	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.00443	0.00864	CbGpPWpGaD
Cytarabine—CDA—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00377	0.00734	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—SDHB—adrenal gland cancer	0.0036	0.00702	CbGpPWpGaD
Cytarabine—POLA1—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.00329	0.0064	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.00324	0.00633	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.0032	0.00625	CbGpPWpGaD
Cytarabine—POLD1—Telomere Maintenance—TERT—adrenal gland cancer	0.00308	0.00601	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.00301	0.00587	CbGpPWpGaD
Cytarabine—POLE—Telomere Maintenance—TERT—adrenal gland cancer	0.00298	0.0058	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.0028	0.00546	CbGpPWpGaD
Cytarabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.00279	0.00544	CbGpPWpGaD
Cytarabine—SLC29A1—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00261	0.00509	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—RB1—adrenal gland cancer	0.00259	0.00504	CbGpPWpGaD
Cytarabine—POLD1—Chromosome Maintenance—TERT—adrenal gland cancer	0.00257	0.00501	CbGpPWpGaD
Cytarabine—POLE—Chromosome Maintenance—TERT—adrenal gland cancer	0.00248	0.00483	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—RRM1—adrenal gland cancer	0.00232	0.00453	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—SDHD—adrenal gland cancer	0.00232	0.00453	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.00228	0.00445	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—CDKN2A—adrenal gland cancer	0.00227	0.00443	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.00212	0.00414	CbGpPWpGaD
Cytarabine—POLA1—Telomere Maintenance—TERT—adrenal gland cancer	0.00212	0.00414	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00207	0.00404	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SDHB—adrenal gland cancer	0.00207	0.00403	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.00207	0.00403	CbGpPWpGaD
Cytarabine—POLD1—Synthesis of DNA—RB1—adrenal gland cancer	0.00203	0.00396	CbGpPWpGaD
Cytarabine—POLE—Synthesis of DNA—RB1—adrenal gland cancer	0.00196	0.00383	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00193	0.00377	CbGpPWpGaD
Cytarabine—POLD1—DNA Replication—RB1—adrenal gland cancer	0.00191	0.00372	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SDHB—adrenal gland cancer	0.00189	0.00369	CbGpPWpGaD
Cytarabine—POLE—DNA Replication—RB1—adrenal gland cancer	0.00184	0.00359	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—RB1—adrenal gland cancer	0.00177	0.00346	CbGpPWpGaD
Cytarabine—POLA1—Chromosome Maintenance—TERT—adrenal gland cancer	0.00177	0.00345	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—RB1—adrenal gland cancer	0.00174	0.00339	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—MED12—adrenal gland cancer	0.00173	0.00337	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.00173	0.00337	CbGpPWpGaD
Cytarabine—POLD1—S Phase—RB1—adrenal gland cancer	0.00167	0.00325	CbGpPWpGaD
Cytarabine—POLE—S Phase—RB1—adrenal gland cancer	0.00161	0.00314	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00159	0.0031	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.00153	0.00298	CbGpPWpGaD
Cytarabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.00153	0.00298	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.00151	0.00295	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.00149	0.00291	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.00148	0.00289	CbGpPWpGaD
Cytarabine—POLA1—Synthesis of DNA—RB1—adrenal gland cancer	0.0014	0.00273	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—RRM1—adrenal gland cancer	0.00133	0.0026	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SDHD—adrenal gland cancer	0.00133	0.0026	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.00131	0.00256	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—RB1—adrenal gland cancer	0.00131	0.00256	CbGpPWpGaD
Cytarabine—Gemcitabine—ABCB1—adrenal gland cancer	0.0013	0.0316	CrCbGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—adrenal gland cancer	0.00126	0.00247	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—RB1—adrenal gland cancer	0.00126	0.00246	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PRKACA—adrenal gland cancer	0.00126	0.00246	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00124	0.00241	CbGpPWpGaD
Cytarabine—CDA—Metabolism—RRM1—adrenal gland cancer	0.00122	0.00238	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SDHD—adrenal gland cancer	0.00122	0.00238	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00122	0.00237	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.00121	0.00236	CbGpPWpGaD
Cytarabine—Lamivudine—ABCB1—adrenal gland cancer	0.00118	0.0288	CrCbGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.00118	0.00229	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SDHB—adrenal gland cancer	0.00117	0.00229	CbGpPWpGaD
Cytarabine—POLA1—S Phase—RB1—adrenal gland cancer	0.00115	0.00224	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SDHB—adrenal gland cancer	0.0011	0.00215	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TOP2A—adrenal gland cancer	0.00109	0.00212	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00107	0.00209	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.00106	0.00208	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TOP2A—adrenal gland cancer	0.00105	0.00205	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00104	0.00202	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.00103	0.00202	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GNAS—adrenal gland cancer	0.00102	0.002	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00101	0.00197	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—ABCB1—adrenal gland cancer	0.001	0.00196	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.001	0.00196	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—MED12—adrenal gland cancer	0.000994	0.00194	CbGpPWpGaD
Cytarabine—ABCC10—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000985	0.00192	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000982	0.00191	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—PRKACA—adrenal gland cancer	0.000958	0.00187	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.000936	0.00182	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—PRKACA—adrenal gland cancer	0.000925	0.0018	CbGpPWpGaD
Cytarabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000921	0.0018	CbGpPWpGaD
Cytarabine—CDA—Metabolism—MED12—adrenal gland cancer	0.000909	0.00177	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000901	0.00176	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000877	0.00171	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000837	0.00163	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000796	0.00155	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000794	0.00155	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000781	0.00152	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—RRM1—adrenal gland cancer	0.000757	0.00147	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SDHD—adrenal gland cancer	0.000757	0.00147	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TOP2A—adrenal gland cancer	0.000749	0.00146	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00074	0.00144	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.00074	0.00144	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000737	0.00144	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	0.000733	0.00143	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PRKACA—adrenal gland cancer	0.000725	0.00141	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SDHD—adrenal gland cancer	0.000711	0.00139	CbGpPWpGaD
Cytarabine—DCK—Metabolism—RRM1—adrenal gland cancer	0.000711	0.00139	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—POMC—adrenal gland cancer	0.000689	0.00134	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PRKACA—adrenal gland cancer	0.000663	0.00129	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000663	0.00129	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—PRKACA—adrenal gland cancer	0.000659	0.00128	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TERT—adrenal gland cancer	0.000652	0.00127	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TERT—adrenal gland cancer	0.000629	0.00123	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.000609	0.00119	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000593	0.00116	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GNAS—adrenal gland cancer	0.000588	0.00115	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—ABCB1—adrenal gland cancer	0.000577	0.00112	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000567	0.00111	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.000567	0.00111	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—MED12—adrenal gland cancer	0.000564	0.0011	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—adrenal gland cancer	0.00055	0.00107	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000548	0.00107	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GNAS—adrenal gland cancer	0.000538	0.00105	CbGpPWpGaD
Cytarabine—DCK—Metabolism—MED12—adrenal gland cancer	0.00053	0.00103	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ABCB1—adrenal gland cancer	0.000528	0.00103	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	0.000522	0.00102	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RB1—adrenal gland cancer	0.000507	0.000989	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000499	0.000972	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RB1—adrenal gland cancer	0.00049	0.000955	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000482	0.000939	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.00047	0.000916	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TERT—adrenal gland cancer	0.000449	0.000874	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2A—adrenal gland cancer	0.000446	0.000869	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.000437	0.000852	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2A—adrenal gland cancer	0.000431	0.000839	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000428	0.000834	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PRKACA—adrenal gland cancer	0.000412	0.000802	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.000408	0.000794	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000399	0.000778	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—POMC—adrenal gland cancer	0.000396	0.000772	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000395	0.000769	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00039	0.000761	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PRKACA—adrenal gland cancer	0.000387	0.000754	CbGpPWpGaD
Cytarabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000382	0.000745	CbGpPWpGaD
Cytarabine—CDA—Metabolism—POMC—adrenal gland cancer	0.000362	0.000706	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RB1—adrenal gland cancer	0.000349	0.00068	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000343	0.000669	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GNAS—adrenal gland cancer	0.000334	0.00065	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.000328	0.000639	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ABCB1—adrenal gland cancer	0.000327	0.000638	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000327	0.000638	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—adrenal gland cancer	0.000316	0.000616	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GNAS—adrenal gland cancer	0.000314	0.000611	CbGpPWpGaD
Cytarabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00031	0.000604	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ABCB1—adrenal gland cancer	0.000308	0.0006	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2A—adrenal gland cancer	0.000307	0.000598	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.000306	0.000596	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000305	0.000594	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—adrenal gland cancer	0.000289	0.000563	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.000282	0.000549	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.000282	0.000549	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000265	0.000517	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.000263	0.000512	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.000263	0.000512	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00026	0.000507	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—adrenal gland cancer	0.000248	0.000484	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000247	0.000482	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000243	0.000473	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—adrenal gland cancer	0.00024	0.000467	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—POMC—adrenal gland cancer	0.000225	0.000438	CbGpPWpGaD
Cytarabine—DCK—Metabolism—POMC—adrenal gland cancer	0.000211	0.000412	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.00021	0.000409	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.000196	0.000382	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—adrenal gland cancer	0.000179	0.000349	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—adrenal gland cancer	0.000171	0.000333	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—adrenal gland cancer	0.000168	0.000328	CbGpPWpGaD
Cytarabine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000165	0.000321	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.000153	0.000299	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000147	0.000287	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.000143	0.000278	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000124	0.000242	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000122	0.000238	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000116	0.000226	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000114	0.000221	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	9.48e-05	0.000185	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	9.48e-05	0.000185	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—POMC—adrenal gland cancer	8.36e-05	0.000163	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—POMC—adrenal gland cancer	7.79e-05	0.000152	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.07e-05	0.000138	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	6.67e-05	0.00013	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	6.22e-05	0.000121	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.16e-05	0.000101	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.18e-05	8.15e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.1e-05	8e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.81e-05	5.49e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.25e-05	4.38e-05	CbGpPWpGaD
